http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004100871-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c476f50ba77ab8ef26b22f3154901689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc6c2e9e63b6561f2f46b1de31f6379
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42c5d2df2b0f6907d5050acf9970562e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
filingDate 2004-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99c46486e11ecc6ff02e324e07f2b21a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a34b167ae38d3b2867fe9da446b3694
publicationDate 2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004100871-A3
titleOfInvention Combination of an aldosterone receptor antagonist and a renin inhibitor
abstract Novel combinations, compositions, and therapeutic methods of treatment of a hypertension, cardiovascular disease, renal dysfunction, edema, cerebrovascular disease, or insulinopathy pathological condition in a subject, wherein the methods comprise the administration of a combination of one or more aldosterone receptor antagonists and one or more renin inhibitors.
priorityDate 2003-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4559332-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0209760-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5559111-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394333

Total number of triples: 21.